Crossingbridge Advisors, LLC
- SEC CIK
- 0001770024
- Latest filing
- Aug 13, 2026
TDAC holding history
Translational Development Acquisition Corp. in every 13F filed by Crossingbridge Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TDAC overviewAll 13F holders of TDACFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −290,100−100.0% | Sold out | Holders |
| Q1 2026 | 290,100 | $3.06M | 0.6% | +40,100+16.0% | Added | Holders |
| Q4 2025 | 250,000 | $250.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 250,000 | $250.0K | 0.1% | −150,000−37.5% | Reduced | Holders |
| Q2 2025 | 400,000 | $4.11M | 3.6% | −185,000−31.6% | Reduced | Holders |
| Q1 2025 | 585,000 | $5.90M | 3.1% | +585,000 | New | Holders |